Status:

COMPLETED

The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia

Lead Sponsor:

Second Affiliated Hospital of Wenzhou Medical University

Conditions:

Phthalate Exposure

Preeclampsia

Eligibility:

FEMALE

18-40 years

Brief Summary

Phthalates are a group of ubiquitous synthetic endocrine-disrupting chemicals. Fetal and neonatal periods are particularly susceptible to endocrine disorders, which prenatal exposure to phthalates cau...

Eligibility Criteria

Inclusion

  • Singleton pregnancy
  • Term pregnancy with the gestational age of 37-40 weeks

Exclusion

  • Maternal systemic diseases (hypertension disorders, immunological diseases) or pregnant complications (polyhydramnios, oligohydramnios, diabetes mellitus, intrahepatic cholestasis of pregnancy)
  • Delivery before 37 weeks or after 40 weeks

Key Trial Info

Start Date :

January 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 31 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04777929

Start Date

January 1 2021

End Date

October 31 2022

Last Update

November 29 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China, 325027